People
There is a concept held dear by many that there is strength in diversity. At South San Francisco-based Genentech, that is a concept also embraced by Sara Kenkare-Mitra, senior vice president of development sciences.
The new designation could speed up the time for approval and could also provide a period of market exclusivity for generics of branded medicines that have no competition.
The first trial of male birth control gel to check its safety is underway. If approved, this could be the first male hormonal birth control on the market.
LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology
LenioBio GmbH announces the appointment of Dr. Lorenz M. Mayr, Prof. Govind Rao, and Prof. Stefan Schillberg to LenioBio’s Scientific Advisory Board (SAB).
A rap video extolling the virtues of prescribing a powerful fentanyl-based pain killer to patients beyond what the drug was initially intended, is coming back to haunt Insys founder John Kapoor.
“This is Medidata’s first office in Boston, and the company is excited for the opportunity over the next several years to tap into the amazing life sciences and technology skills that Boston can offer,” said Medidata’s chief people officer.
GeoVax Labs, Inc., a biotechnology company developing human vaccines, today published an open letter to U.S. Department of Health and Human Services Secretary Alex Azar in response to the HHS initiative “Ending the HIV Epidemic: A Plan for America.”
InflaRx N.V. announced that Mr. Richard Brudnick has been appointed, as interim Non-Executive Director to the Board of Directors of InflaRx N.V.
Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.
There is a new chief executive officer guiding Cambridge, Mass.-based Cadent Therapeutics. This morning, the company announced long-time industry veteran Jodie Morrison will take over the reins of the company.
PRESS RELEASES